This announcement is a separate document:
莱美药业：2023年半年度报告摘要
Laimei Pharmaceuticals: Summary of the 2023 Semi-Annual Report
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Latest
14:58
The British Pound against the US Dollar has fallen to its lowest level since November 2023.
14:58
ShanDong Province has introduced new policies to promote the high-quality development of the broadcasting and television industry.
14:54
Vanke: A series of measures will be taken to address the debt repayment in 2025.
China Vanke Co.,Ltd.+0.14%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.